Q&A: BARDA wants to back tech that can combat multiple infections, says director
The director of BARDA’s medical countermeasures programs, Robert Johnson, PhD, talks about what the agency is planning to invest in the future.
Interviews
Q&A: Increasing awareness around digital therapeutics key to realising full potential
Q&A: Regulatory reform necessary to improve obesity drug access
Bupa is leveraging its unique position to develop IoT and AI features
Q&A: Exploring the challenges behind oncology trials
Q&A: Tackling the rise of fake anti-obesity drugs on the market
Q&A: European Pharmaceutical legislation: hindrance or help?
Q&A: UK pharma manufacturing prepares for imminent shake up in 2024
